AHA, AAMC express support for 340B program

Oct 05, 2017 - 02:51 PM

The 340B Drug Pricing Program “has enabled hospitals and health systems to support and expand access and services consistent with their mission and the program’s original and ongoing charge,” the AHA and Association of American Medical Colleges today told leaders of the House Energy and Commerce Committee and its Subcommittee on Oversight and Investigations. In the letter, AHA and AAMC provided examples of how hospitals and health systems have used 340B savings to expand access and services. These include supporting neonatal intensive care units and training for physicians to care for vulnerable newborns; providing low-income patients with free outpatient drugs; and pharmacist counseling services for medication therapy disease management, including telephone consultations for outpatients with conditions such as diabetes, hypertension and asthma. The letter also notes that the 340B program is not federally funded, and 340B sales are less than 3% of the total U.S. drug market. The Oversight and Investigations Subcommittee will hold a hearing on the 340B program Oct. 11.

Related News Articles

Headline
HHS announces revised 340B Rebate Model Pilot Program; see AHA’s statement shared with media 
The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, allowing qualifying drug manufacturers…
Headline
CMS issues hospital inpatient payment final rule for FY 2027
The Centers for Medicare & Medicaid Services today issued a final rule that would increase Medicare rates by a net 2.3% in fiscal year 2027, compared with…
Headline
CMS releases 2025 report on program audits, enforcement for Medicare Advantage, Part D 
The Centers for Medicare & Medicaid Services July 27 released its Contract Year 2025 Part C and Part D Program Audit and Enforcement Report, outlining key…
Headline
Court rules that companies may not impose 340B rebate model without HHS approval
The U.S. District Court for the District of Columbia July 21 upheld a lower court’s decision that Section 340B of the Public Health Service Act does not …
Headline
CMS posts updated FAQ on PAMA clinical laboratory private payer data reporting 
The Centers for Medicare & Medicaid Services has released an updated FAQ on Protecting Access to Medicare Act private payer data reporting. The deadline is…
Headline
Draft guidance released for 2028 cycle of Medicare drug price negotiations 
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…